ExodusPoint Capital Management’s Nuvation Bio NUVB Stock Holding History

ExodusPoint Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$702K	Buy	163,687 +103,379	+171%	+$576K	0.01%	1097
2025 Q4	$540K	Buy	60,308 +41,934	+228%	+$260K	﹤0.01%	1169
2025 Q3	$68K	Sell	18,374 -73,876	-80%	-$201K	﹤0.01%	1450
2025 Q2	$180K	Buy	+92,250	New	+$192K	﹤0.01%	1326
2025 Q1	–	Sell	-77,280	Closed	-$206K	–	1834
2024 Q4	$206K	Sell	77,280 -5,167	-6%	-$13.3K	﹤0.01%	1359
2024 Q3	$189K	Buy	+82,447	New	+$251K	﹤0.01%	1462
2023 Q1	–	Sell	-26,181	Closed	-$50K	–	2019
2022 Q4	$50K	Buy	+26,181	New	+$53K	﹤0.01%	1546
2021 Q2	–	Sell	-159,162	Closed	-$1.66M	–	2662
2021 Q1	$1.66M	Buy	+159,162	New	+$1.78M	0.02%	641

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ExodusPoint Capital Management's NUVB Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Nuvation Bio (NUVB) stake by 171% in Q1 2026, buying an estimated $576K and bringing the position to 163,687 shares worth $702K. The position accounts for 0.01% of the portfolio, ranked #1097.

ExodusPoint Capital Management first reported a position in NUVB in Q1 2021 and has held it in 8 quarters since. The position peaked at $1.66M in Q1 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

ExodusPoint Capital Management held 163,687 shares of Nuvation Bio worth $702K as of Q1 2026.
ExodusPoint Capital Management bought 103,379 Nuvation Bio shares in Q1 2026, an estimated $576K.
Nuvation Bio made up 0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1097 holding.
ExodusPoint Capital Management first reported a position in Nuvation Bio in Q1 2021 and has held it in 8 quarters since.
ExodusPoint Capital Management's Nuvation Bio position peaked at $1.66M in Q1 2021.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.